Alerts will be sent to your verified email
Verify Email
GUJTERC
|
Guj. Terce Lab
|
Omkar Pharmachem
|
Venmax Drugs&Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.73 % | 2.2 % | 1.17 % |
|
5yr average Equity Multiplier
|
3.3 | 1.05 | 0.08 |
|
5yr Average Asset Turnover Ratio
|
1.76 | 0.05 | 0.14 |
|
5yr Avg Net Profit Margin
|
-2.57 % | 44.95 % | -19.62 % |
|
Price to Book
|
3.32 | 3.15 | 3.29 |
|
P/E
|
0.0 | 350.0 | 35.24 |
|
5yr Avg Cash Conversion Cycle
|
-20.6 Days | 49.27 Days | 288.55 Days |
|
Inventory Days
|
40.01 Days | 0.0 | 5.2 Days |
|
Days Receivable
|
39.02 Days | 49.27 Days | 430.69 Days |
|
Days Payable
|
100.7 Days | 0.0 | 141.12 Days |
|
5yr Average Interest Coverage Ratio
|
1.07 | 7.4 | -260.56 |
|
5yr Avg ROCE
|
3.46 % | 2.6 % | -47.43 % |
|
5yr Avg Operating Profit Margin
|
-0.49 % | 44.39 % | -65.91 % |
|
5 yr average Debt to Equity
|
0.63 | 0.06 | -0.45 |
|
5yr CAGR Net Profit
|
-17.21 % | -1.89 % | -42.57 % |
|
5yr Average Return on Assets
|
-3.57 % | 2.09 % | 199.45 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
40.03 % | 0.03 % | 15.14 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
3.81 % | 0.0 | -7.99 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Guj. Terce Lab
|
Omkar Pharmachem
|
Venmax Drugs&Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|